Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • BOC Sciences January 2023 Promo: An Economical (Bio)chemical Source for New Year Projects

    Feb 7, 2023, 10:36 AM by
    As the new year approaches, BOC Sciences' January promotion is bang on time, as usual, to thank all regular customers for the year-round support and to welcome new partners to join.
    Full story
  • Hexarad radiology technology cuts scan allocation time by 90%

    Feb 7, 2023, 10:35 AM by
    The Hexarad auto-allocation tool automatically assigns scans to the most appropriate radiologist, cutting down admin burden and leading to faster and more accurate scan results.
    Full story
  • Deepcell Releases Sample Datasets to Highlight Morphology-Driven Data

    Feb 7, 2023, 01:00 AM by User Not Found
    Bio-IT World | Deepcell, a pioneer in AI-powered single cell analysis to fuel deep biological discoveries, has released three datasets, available online, to enable researchers to explore novel high-dimensional morphology data. The datasets were generated on Deepcell’s high-throughput platform, comprised of imaging and sorting instrumentation, AI models, and a software suite.
    Full story
  • RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies

    Feb 6, 2023, 09:54 AM by
    RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies Risk-Based Quality Management: 10 Years of enhancing Quality, Accuracy, and Integrity across all Clinical Trial Data
    Full story
  • Creative Enzymes Introduces Two Enzyme Engineering Methods to Accelerate Related Research

    Feb 6, 2023, 09:54 AM by
    Full story
  • Verisense Health Introduces Eminent New Board of Advisors

    Feb 6, 2023, 09:54 AM by
    Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.
    Full story
  • Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

    Feb 6, 2023, 09:52 AM by
    Full story
  • International Conference on Veterinary Science Medicine and Research

    Feb 6, 2023, 09:51 AM by
    Worldwide veterinarian scientist and researcher are welcome to gather in our reputable conference and sharing the thoughts of experience in the field of the veterinary science medicine and research in Dubai, UAE on DEC 04-05, 2023 and Veterinary Science medicine and research webinar on DEC 11-12, 2023.
    Full story
  • DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

    Feb 3, 2023, 09:25 AM by
    DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform
    Full story
  • NCCHD in Japan Demonstrates Improved Diagnostics Rate for Rare Disease Diagnostics using OmniTier’s CompStor® Genomic Analysis Platform

    Feb 3, 2023, 09:24 AM by
    Benchmark WES re-analysis study by NCCHD, Japan using OmniTier’s AI-based variant interpretation platform achieves around a 42% diagnostics rate, a 7% improvement in the average rate for diagnosing rare diseases
    Full story
  • AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

    Feb 3, 2023, 09:24 AM by
    AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials Seamless integration of adherence and research data protects participant safety and data quality, with no additional burden for clinical trial sites or participants
    Full story
  • The Carbon Footprint Impact of Cloud Solutions

    Feb 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | While those in the life sciences appreciate the importance of curbing greenhouse gas emissions and the pressing impact of global warming, actionable steps toward going green have yet to permeate all facets of cloud computing research. As such, the current state of affairs in bioinformatic computing is not particularly green.
    Full story
  • Alfa Chemistry Newly Releases Photosensitizers, Photocatalysts, and Quantum Dots

    Feb 2, 2023, 09:49 AM by
    Full story
  • What is Electroplating Intermediate?

    Feb 2, 2023, 09:49 AM by
    Electroplating intermediates refer to a class of fine chemicals used as electroplating additives. Unlike the salt used in the plating production process, the electroplating intermediate is an additive material for electroplating modification in terms of grain size, gloss, thickness, and plating speed.
    Full story
  • Creative Biogene Release Fungal ITS Sequencing to Support Microbial Identification

    Feb 2, 2023, 09:47 AM by
    Full story
  • Microbiosci Designs Pseudomonas Fluorescens Fermentation to Support Clinical Research for Several Disease Disorders

    Feb 2, 2023, 09:46 AM by
    Full story
  • Creative Biogene Launches Bioproduction Cell Line Development to Support The Process of Biopharmaceutical Manufacturing

    Feb 2, 2023, 09:46 AM by
    Full story
  • Creative Bioarray Offers More Than 2,000 Tumor Cells from Human and Animals

    Feb 2, 2023, 09:45 AM by
    Full story
  • Creative Bioarray Constructed More Than 6000 Types of High-quality Tissue Microarrays

    Feb 2, 2023, 09:45 AM by
    Full story
  • DDA Platform Accelerates Drug Discovery Process with Wide Range of Assays and Services

    Feb 2, 2023, 09:45 AM by
    Full story
  • «
  • 101 (current)
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy